Perspectives On Optimizing Chronic Heart Failure Care Beyond Randomised Controlled Trials – What do we Consolidate and how do we Plan for the Future?-Reference-Cited by-同舟云学术

Perspectives On Optimizing Chronic Heart Failure Care Beyond Randomised Controlled Trials – What do we Consolidate and how do we Plan for the Future?

Published:2019-05-06 Issue:3 Volume:15 Page:158-160
ISSN:1573-403X
Container-title:Current Cardiology Reviews
language:en
Short-container-title:CCR

Author:

Iyngkaran Pupalan¹,Thomas Merlin²,Majoni Sandawana W.³

Affiliation:

1. Consultant Cardiologist Heart West and Senior Lecturer Flinders University, NT Medical School, Darwin, Australia

2. Biochemistry of Diabetes Complications, The Department of Diabetes, Monash University, Melbourne, Australia

3. Clinical Dean Royal Darwin Hospital, TEHS, Renal Transplantation, Royal Darwin Hospital, Department of Nephrology, Division of Medicine, P.O. Box 41326, Tiwi, Darwin, Australia

Abstract

Publisher

Bentham Science Publishers Ltd.

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference13 articles.

1. Iyngkaran P. Curr Cardiol Rev, Editorial: Optimizing chronic heart failure care beyond randomised controlled trials - What are the problem areas and potential solutions?,, 2016, 12,, 164-165,

2. . Heart Lung Circ, Atherton JJ, Sindone A, et al National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Guidelines for the Prevention, detection, and management of heart failure in Australia 2018.,NHFA CSANZ Heart Failure Guidelines Working Group, 2018, 27,, 1123-1208,

3. Krumholz HM, Currie PM, Riegel B. Circulation, American Heart Association Disease Management Taxonomy Writing Group. A taxonomy for disease management: A scientific statement from the American Heart Association Disease Management Taxonomy Writing Group.,, 2006, 14,, 1432-1445,

4. Iyngkaran P, Liew D, Neil C, Driscoll A, Marwick TH, Hare DL. Clin Med Insights Cardiol, Moving from heart failure guidelines to clinical practice: Gaps contributing to readmissions in patients with multiple comorbidities and older age.,, 2018, 12,, 1179546818809358-,

5. Fitzgerald AA, Allen LA, Masoudi FA. Ann N Y Acad Sci, The evolving landscape of quality measurement for heart failure.,, 2012, 1254,, 131-139,